This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Bionomics 과거 수익 실적
과거 기준 확인 0/6
Bionomics's earnings have been declining at an average annual rate of -3.4%, while the Biotechs industry saw earnings growing at 16% annually. Revenues have been declining at an average rate of 42.6% per year.
주요 정보
-3.4%
수익 성장률
27.8%
EPS 성장률
Biotechs 산업 성 장 | 9.6% |
매출 성장률 | -42.6% |
자기자본 수익률 | -52.2% |
순이익 | -413.9% |
최근 수익 업데이트 | 31 Dec 2022 |
최근 과거 실적 업데이트
Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30수익 및 비용 분석
Bionomics 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
31 Dec 22 | 6 | -25 | 7 | 0 |
30 Sep 22 | 6 | -23 | 7 | 0 |
30 Jun 22 | 6 | -22 | 8 | 0 |
31 Mar 22 | 3 | -22 | 8 | 0 |
31 Dec 21 | 0 | -22 | 8 | 0 |
30 Sep 21 | 1 | -15 | 7 | 0 |
30 Jun 21 | 1 | -9 | 6 | 0 |
31 Mar 21 | 1 | -4 | 5 | 0 |
31 Dec 20 | 2 | 1 | 5 | 0 |
30 Sep 20 | 2 | -3 | 5 | 0 |
30 Jun 20 | 3 | -6 | 5 | 0 |
31 Dec 19 | 6 | -5 | 5 | 0 |
30 Sep 19 | 7 | -8 | 6 | 0 |
30 Jun 19 | 7 | -10 | 8 | 0 |
31 Mar 19 | 8 | -20 | 11 | 0 |
31 Dec 18 | 8 | -28 | 11 | 0 |
30 Sep 18 | 10 | -27 | 11 | 0 |
30 Jun 18 | 12 | -25 | 11 | 0 |
31 Mar 18 | 19 | -15 | 9 | 0 |
31 Dec 17 | 27 | -6 | 8 | 0 |
30 Sep 17 | 27 | -6 | 8 | 0 |
30 Jun 17 | 27 | -7 | 8 | 0 |
31 Mar 17 | 22 | -12 | 10 | 0 |
31 Dec 16 | 16 | -17 | 12 | 0 |
30 Sep 16 | 18 | -17 | 11 | 0 |
30 Jun 16 | 19 | -17 | 11 | 0 |
31 Mar 16 | 19 | -19 | 10 | 0 |
31 Dec 15 | 18 | -21 | 9 | 0 |
30 Sep 15 | 17 | -19 | 9 | 0 |
30 Jun 15 | 15 | -17 | 9 | 0 |
31 Mar 15 | 22 | -6 | 7 | 0 |
31 Dec 14 | 29 | 4 | 5 | 0 |
30 Sep 14 | 28 | 4 | 5 | 0 |
30 Jun 14 | 27 | 3 | 5 | 0 |
31 Mar 14 | 19 | -5 | 5 | 0 |
31 Dec 13 | 12 | -13 | 5 | 0 |
30 Sep 13 | 12 | -11 | 5 | 0 |
30 Jun 13 | 12 | -10 | 5 | 0 |
31 Mar 13 | 13 | -7 | 5 | 0 |
31 Dec 12 | 13 | -4 | 4 | 0 |
30 Sep 12 | 12 | -3 | 4 | 0 |
양질의 수익: BNO is currently unprofitable.
이익 마진 증가: BNO is currently unprofitable.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: BNO is unprofitable, and losses have increased over the past 5 years at a rate of 3.4% per year.
성장 가속화: Unable to compare BNO's earnings growth over the past year to its 5-year average as it is currently unprofitable
수익 대 산업: BNO is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-6.2%).
자기자본 수익률
높은 ROE: BNO has a negative Return on Equity (-52.21%), as it is currently unprofitable.